Investor Home

Our History

We were founded in May 2012 in Leiden the Netherlands with the goal of developing a treatment for cystic fibrosis (CF). The founding team - Daniel de Boer, Gerard Platenburg, Dinko Valerio and Henri Termeer (28 February 1946 – 12 May 2017) - pulled together a team of motivated RNA and CF experts to work on a unique RNA therapy for CF. Our innovative and promising technolog Read more

Share Performance

Copyright Nasdaq. Minimum 15 minutes delayed.

IR Contacts

Daniel de Boer
Chief Executive Officer
ProQR Therapeutics N.V.
Phone: +31 88 166 7000
E-mail: info@proqr.com
 
Bonnie Ortega
Director, Investor Relations
Phone: +1 858 245 3983
E-mail: ir@proqr.com

Media Contact

E-mail: pr@proqr.com